EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel anti-reflux biliary metal stent with a distal tapered end for distal malignant biliary obstruction: a feasibility study

Shinpei Doi, Yuta Namura, Tomohiro Kikuyama, Go Saito, Takako Adachi, Kotaro Matsumoto, Ayako Watanabe, Hiromichi Tsunashima, Nobuhiro Katsukura, Takayuki Tsujikawa, Ichiro Yasuda

Endoscopy International Open · 01.05.2023 · 11 (05) · E460-E465

DOI: 10.1055/a-2039-3853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.05.2023. Verfasst von Shinpei Doi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Kanagawa Japan. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims We developed a self-expandable metallic stent (SEMS) with a distal tapered end to reproduce the physiological bile flow with a pressure gradient due to the difference in the diameter. We aimed to evaluate the safety and efficacy of the newly developed distal tapered covered metal stent (TMS) for distal malignant biliary obstruction (DMBO). Patients and methods This single-center, prospective, single-arm study was conducted in patients with DMBO. The primary endpoint was time to recurrent biliary obstruction (TRBO), and the secondary endpoints were the survival time and incidence of adverse events (AEs).

Results

Thirty-five patients (15 men, 20 women; median age, 81 years [range: 53–92]) were enrolled between December 2017 and December 2019. The primary diseases were pancreatic head cancer in 25 cases, bile duct cancer in eight cases, and ampullary cancer in two cases. TMS was successfully placed in all cases. Acute cholecystitis occurred as an early AE (within 30 days) in two cases (5.7 %). The median TRBO was 503 days, median survival time was 239 days. RBO was observed in 10 cases (28.6 %), and the causes were distal migration in six cases, proximal migration in two cases, biliary sludge in one case, and tumor overgrowth in one case.

Conclusions

Endoscopic placement of the newly developed TMS in patients with DMBO is technically feasible and safe, and the TRBO was remarkably long. The anti-reflux mechanism based on the difference in diameter may be effective, and a randomized controlled trial with a conventional SEMS is required.

Autor:innen und Institutionen

  • Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Kanagawa Japan.
  • Third Department of Internal Medicine, University of Toyama, Toyama, Japan.

Zitieren

APA

Doi, S., Namura, Y., Kikuyama, T., Saito, G., Adachi, T., Matsumoto, K., Watanabe, A., Tsunashima, H., Katsukura, N., Tsujikawa, T., & Yasuda, I. (2023). Novel anti-reflux biliary metal stent with a distal tapered end for distal malignant biliary obstruction: a feasibility study. Endoscopy International Open, 11(05), E460-E465. https://doi.org/10.1055/a-2039-3853

Vancouver

Doi S, Namura Y, Kikuyama T, Saito G, Adachi T, Matsumoto K, et al. Novel anti-reflux biliary metal stent with a distal tapered end for distal malignant biliary obstruction: a feasibility study. Endoscopy International Open. 2023;11(05):E460-E465. doi:10.1055/a-2039-3853

BibTeX
@article{Doi2023,
  author = {Doi, Shinpei and Namura, Yuta and Kikuyama, Tomohiro and Saito, Go and Adachi, Takako and Matsumoto, Kotaro and Watanabe, Ayako and Tsunashima, Hiromichi and Katsukura, Nobuhiro and Tsujikawa, Takayuki and Yasuda, Ichiro},
  title = {Novel anti-reflux biliary metal stent with a distal tapered end for distal malignant biliary obstruction: a feasibility study},
  journal = {Endoscopy International Open},
  year = {2023},
  volume = {11},
  number = {05},
  pages = {E460--E465},
  doi = {10.1055/a-2039-3853}
}
Kostenlos starten →